So, Mounjaro supports weight loss by making us feel less hungry through two mechanisms: Communicating with the brains appetite control centre Slowing the rate that food is digested Research shows that Mounjaro leads to an average weight loss of around 26% after one year
They thereby exceed considerably their original purpose, which was to document that the drugs do not increase cardiovascular risk
So instead, heres a quick run-down and initial thoughts on TRIUMPH-4 topline results which posted today
Anyone interested in pharmacological support for weight management should speak with their GP or be referred to an NHS Tier 3 weight management service, where appropriate assessment and supervised care can be provided safely and legally
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial
Blood sugar and insulin sensitivity Both medications improve glycemic control, but through slightly different pathways